References
Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985; 28: 581–6
Chin N, Brittain DC, Neu HC. In-vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrob Agents Chemother 1986; 29: 298–307
Manek N, Andrews M, Wise R. In-vitro activity of Ro 23-6240, a new trifluoroquinolone derivative, compared with that of other antimicrobial agents. Antimicrob Agents Chemother 1986; 30: 330–2
Cullmann W, Geddes AM, Weidekamm E, et al. Fleroxacin: a rewiew of its chemistry, microbiology, toxicology, pharmacokinetics, clinical efficacy and safety. Int J Antimicrob Agents 1992; 2: 203–30
Wise R, Kirkpatrick B, Ashby J, et al. The pharmacokinetics and tissue penetration of Ro 23-6240, a new fluoroquinolone. Antimicrob Agents Chemother 1987; 31: 161–3
Sahai J, Healy DP, Stotka J, et al. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin. Br J Clin Pharmacol 1993; 35: 302–4
Neuvonen PJ, Kivistö KT, Lehto P. Interference of dairy products with the absorption of ciprofloxacin. Clin Pharmacol Ther 1991; 50: 498–502
Kivistö KT, Ojala-Karlsson P, Neuvonen PJ. Inhibition of norfloxacin absorption by dairy products. Antimicrob Agents Chemother 1992; 36: 489–91
Weidekamm E, Portmann R, Partos C, et al. Single and multiple dose pharmacokinetics of fleroxacin. J Antimicrob Chemother 1988; 22 Suppl. D: 145–54
Neuman M. Clinical pharmacokinetics of the antibacterial 4-quinolones. Clin Pharmacokinet 1988; 14: 96–121
Paton JH, Reeves DS. Fluoroquinolone antibiotics: microbiology, pharmacokinetics and clinical use. Drugs 1988; 36: 193–228
Neuvonen PJ, Kivistö KT. Milk and yogurt do not impair the absorption of ofloxacin. Br J Clin Pharmacol 1992; 35: 302–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoogkamer, J.F.W., Kleinbloesem, C.H. The Effect of Milk Consumption on the Pharmacokinetics of Fleroxacin and Ciprofloxacin in Healthy Volunteers. Drugs 49 (Suppl 2), 346–348 (1995). https://doi.org/10.2165/00003495-199500492-00094
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00094